The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1223
December 5, 2005
View Complete Issue         Table of Contents 2019 
Issue 1223
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Ambien CR for Insomnia
December 5, 2005 (Issue: 1223)
Zolpidem (Ambien - Sanofi-Aventis), a nonbenzodiazepine benzodiazepine receptor agonist, is the most frequently prescribed hypnotic in the US. As its patent approaches expiration, its manufacturer has received FDA approval to market an...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1223
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.